ALDH+ cells are found in up to 48% of breast cancer tumors and are believed to cause late recurrence, and these cells are also associated with an adverse prognosis and poor outcome after conventional anti-cancer drug treatment [5,11,12]. This evidence concerns the gene LDHA and breast cancer.